Dianthus Corp (DNTH) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Dianthus Therapeutics (DNTH) narxlar grafigi ushbu biotexnologiya kompaniyasining dori vositalarini ishlab chiqish bosqichida tashqi moliyalashtirishga bog'liqligini ko'rsatadi, bunda ko'rsatkich 0.00 darajasida turibdi. Biznes teri ostiga yuborish uchun mo'ljallangan, og'ir immun tizimi buzilishlarida talab qilinadigan noyob antitanalarning ishlab chiqilishiga tayanadi. Xavflarni kamaytirish strategiyasi global bozor uchun kam uchraydigan qon va mushak patologiyalariga yo'naltirilgan terapiyalarni yaratishga asoslangan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_DNTH_-_Dianthus-Therapeutics_-_Long-Term-Debt-to-Capital "DNTH: Dianthus Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 31.10.2026 | 👁️GURU.Markets👁️")
Dianthus Therapeutics (DNTH) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Dianthus Therapeutics|DNTH - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati dianthustx.com|DNTH - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Dianthus Therapeutics, Inc.|DNTH - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Dianthus Therapeutics|Tezkor likvidlik ko‘rsatkichi dianthustx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Dianthus Therapeutics Inc - DNTH
Dianthus Therapeutics (DNTH) kompaniyasining komplement inhibitorlari segmentidagi kuchli narx belgilash imkoniyati kompaniyaga noyob antitelalarning ishlab chiqilishini samarali moliyalashtirish imkonini beradi. Ushbu ko'rsatkich moliyaviy richagning darajasini aniqlash uchun aksiyalarning bozor qiymatini hisobga olgan holda, uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchaydi. Jori uzoq muddatli qarzning kapitalga nisbatidagi ko'rsatkichining keskin ortishi balansning haddan tashqari kengayganligidan dalolat beradi, bu esa makroiqtisodiy beqarorlik sharoitida investitsiya risklarini oshiradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Pieris Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati|SVRA (Savara Pharma) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|RIGL: Uzoq muddatli qarzning kapitalga nisbati|ANAB - Uzoq muddatli qarzdorlikning kapitalga nisbati|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati enGene Holdings Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc. (RAPT)|aerovatetx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Aclaris Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati KYTX (kyvernatx.com)|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CABA (Cabaletta Bio Inc.)|VTYX (Ventyx Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc (THTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|eledon.com (ELDN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati ATYR (aTyr Pharmaceuticals)|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti IMA (ImageneBio Inc)|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Equillium (EQ)|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Biopharma Holdings|IMUX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ATRA|Uzoq muddatli qarzning kapitalga nisbati inflarx.de (IFRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET (Adicet Bio Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati INmune Bio Corporation|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SABS|AKTX (Akari Therapeutics PLC) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzdorlikning kapitalga nisbati q32bio.com|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|EDSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Carisma Therapeutics CARM|XTLB: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi APVO (Aptevo)|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli kreditlarning kapitalga nisbati ADTX|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati REVB|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CALI (CalciMedica Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|HOOK (hookipapharma.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|THRD (Third Harmonic Bio) - Uzoq muddatli qarzning o'z kapitaliga nisbati